Matilde Calopa

2.6k total citations
49 papers, 1.0k citations indexed

About

Matilde Calopa is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Matilde Calopa has authored 49 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Neurology, 23 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Matilde Calopa's work include Parkinson's Disease Mechanisms and Treatments (26 papers), Neurological disorders and treatments (24 papers) and Genetic Neurodegenerative Diseases (17 papers). Matilde Calopa is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (26 papers), Neurological disorders and treatments (24 papers) and Genetic Neurodegenerative Diseases (17 papers). Matilde Calopa collaborates with scholars based in Spain, United States and Netherlands. Matilde Calopa's co-authors include Francesc Valldeoriola, Eduardo Tolosa, Mario Ezquerra, Marı́a José Martı́, Serge Jaumà, Jorge Hernández‐Vara, Jaume Campdelacreu, Carme Junqué, Antonio Callén and Jordi Bas and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Matilde Calopa

48 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matilde Calopa Spain 19 790 303 234 194 149 49 1.0k
Brigida Minafra Italy 17 647 0.8× 299 1.0× 147 0.6× 259 1.3× 134 0.9× 35 1.0k
Davide Martino United Kingdom 13 869 1.1× 193 0.6× 175 0.7× 114 0.6× 158 1.1× 19 1.1k
Eva Schaeffer Germany 18 769 1.0× 209 0.7× 223 1.0× 167 0.9× 145 1.0× 44 1.1k
Avner Thaler Israel 21 973 1.2× 189 0.6× 430 1.8× 215 1.1× 239 1.6× 71 1.3k
Beatrice Heim Austria 14 706 0.9× 258 0.9× 170 0.7× 129 0.7× 131 0.9× 50 996
Christopher Kobylecki United Kingdom 20 563 0.7× 284 0.9× 213 0.9× 97 0.5× 175 1.2× 65 1.0k
Pavanni Ratnagopal Singapore 22 1.2k 1.5× 493 1.6× 258 1.1× 396 2.0× 174 1.2× 53 1.6k
Melinda S. Burnett United States 10 766 1.0× 278 0.9× 171 0.7× 171 0.9× 67 0.4× 15 916
Antònia Campolongo Spain 15 717 0.9× 278 0.9× 188 0.8× 97 0.5× 206 1.4× 36 894
María José Martí Spain 11 619 0.8× 168 0.6× 262 1.1× 139 0.7× 58 0.4× 14 760

Countries citing papers authored by Matilde Calopa

Since Specialization
Citations

This map shows the geographic impact of Matilde Calopa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matilde Calopa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matilde Calopa more than expected).

Fields of papers citing papers by Matilde Calopa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matilde Calopa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matilde Calopa. The network helps show where Matilde Calopa may publish in the future.

Co-authorship network of co-authors of Matilde Calopa

This figure shows the co-authorship network connecting the top 25 collaborators of Matilde Calopa. A scholar is included among the top collaborators of Matilde Calopa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matilde Calopa. Matilde Calopa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calopa, Matilde, et al.. (2025). Striato-cortical connectivity patterns predict clinical profiles in Huntington’s disease. NeuroImage Clinical. 46. 103788–103788.
2.
Calopa, Matilde, et al.. (2024). Disentangling the neurobiological bases of temporal impulsivity in Huntington's disease. Brain and Behavior. 14(3). e3335–e3335. 2 indexed citations
3.
Calopa, Matilde, et al.. (2024). Cognitive engagement may slow clinical progression and brain atrophy in Huntington’s disease. Scientific Reports. 14(1). 30156–30156. 1 indexed citations
4.
Santos‐García, Diego, Marta Blázquez Estrada, Matilde Calopa, et al.. (2021). Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project. Brain Sciences. 11(8). 1027–1027. 9 indexed citations
5.
Santos‐García, Diego, María Álvarez Saúco, Matilde Calopa, et al.. (2021). MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice. Diagnostics. 12(1). 55–55. 3 indexed citations
6.
7.
Kulisevsky, Jaime, Helena Bejr‐Kasem, Saül Martínez‐Horta, et al.. (2020). Subclinical affective and cognitive fluctuations in Parkinson's disease: a randomized double-blind double-dummy study of Oral vs. Intrajejunal Levodopa. Journal of Neurology. 267(11). 3400–3410. 8 indexed citations
8.
Escrichs, Anira, Susana Subirà, Matilde Calopa, et al.. (2018). An active cognitive lifestyle as a potential neuroprotective factor in Huntington's disease. Neuropsychologia. 122. 116–124. 15 indexed citations
9.
Catalán, María José, Angelo Antonini, Matilde Calopa, et al.. (2017). Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?. eNeurologicalSci. 8. 44–53. 10 indexed citations
10.
Rodríguez‐Molinero, Alejandro, Albert Samà, David A. Pérez-Martínez, et al.. (2015). Validation of a Portable Device for Mapping Motor and Gait Disturbances in Parkinson’s Disease. JMIR mhealth and uhealth. 3(1). e9–e9. 44 indexed citations
11.
Pont‐Sunyer, Claustre, Álex Iranzo, Carles Gaig, et al.. (2015). Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers. PLoS ONE. 10(7). e0132368–e0132368. 66 indexed citations
12.
Calopa, Matilde, Jordi Bas, Antonio Callén, & M Mestre. (2010). Apoptosis of peripheral blood lymphocytes in Parkinson patients. Neurobiology of Disease. 38(1). 1–7. 62 indexed citations
13.
Sánchez‐Castañeda, Cristina, Ramón Reñé, Blanca Ramı́rez-Ruiz, et al.. (2010). Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia. Movement Disorders. 25(5). 615–622. 93 indexed citations
14.
Alentorn, Agustí, Antoni Palasí, Jaume Campdelacreu, et al.. (2009). Pelvic dyskinesia with an outstanding response to tetrabenazine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(5). 847–848. 3 indexed citations
15.
Terni, Beatrice, María Rey, Susana Boluda, et al.. (2007). Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer’s disease. Acta Neuropathologica. 113(4). 403–416. 35 indexed citations
16.
Oliva, Rafael, Eduardo Tolosa, Mario Ezquerra, et al.. (1998). Significant Changes in the Tau A0 and A3 Alleles in Progressive Supranuclear Palsy and Improved Genotyping by Silver Detection. Archives of Neurology. 55(8). 1122–1122. 56 indexed citations
17.
Sánchez, Aurora, Montserrat Milà, Sergi Castellvı́-Bel, et al.. (1997). [Molecular analysis of the IT15 gene in 79 Spanish families with Huntington's disease: diagnostic confirmation and presymptomatic diagnosis].. PubMed. 108(18). 687–90. 3 indexed citations
18.
Espino, Ana M., Jordi Llorens, Matilde Calopa, et al.. (1995). Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion. Brain Research. 669(1). 19–25. 16 indexed citations
19.
Espino, Ana M., et al.. (1995). CSF somatostatin increase in patients with early parkinsonian syndrome. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 9(2-3). 189–196. 11 indexed citations
20.
Espino, Ana M., Avelina Tortosa, Ramón Bartrons, et al.. (1994). Stereotaxic Administration of 1‐Methyl‐4‐Phenylpyridinium Ion (MPP+) Decreases Striatal Fructose 2,6‐Bisphosphate in Rats. Journal of Neurochemistry. 62(5). 1913–1920. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brigida Minafra Breakdown of academic impact, for papers by Davide Martino Breakdown of academic impact, for papers by Eva Schaeffer Breakdown of academic impact, for papers by Avner Thaler Breakdown of academic impact, for papers by Beatrice Heim Breakdown of academic impact, for papers by Christopher Kobylecki Breakdown of academic impact, for papers by Pavanni Ratnagopal Breakdown of academic impact, for papers by Melinda S. Burnett Breakdown of academic impact, for papers by Antònia Campolongo Breakdown of academic impact, for papers by María José Martí
Rankless by CCL
2026